Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigadexa vs Individual Components in Bacterial Ocular Inflammation
NCT00732446Phase 3Completed
- Sponsor
- Federal University of São Paulo
- Start
- Aug 2008
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of moxifloxacin and dexamethasone in blepharitis, keratitis and bacterial conjunctivitis (BC) (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Evaluation of ocular sign/symptoms at Day 8. Started Aug 2008; status: completed.
02
Drugs
moxifloxacindexamethasone
03
Conditions
blepharitiskeratitisbacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00732446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732446.